TP53 and cancer: (PMID:31346036) It was found that after DNA damage, FBXW7 can mediate P53 degradation, which allows cells to resume proliferation and may have a potentially detrimental effect on cancer outcomes (Elizabeth Caldon, 2020; Galindo-Moreno et al., 2020).